Contents

Recent Patents on CNS Drug Discovery (Discontinued), Volume 2 - Number 3

Rho-ROCK Inhibitors for the Treatment of CNS Injury

, 2(3): 173 - 179

Takekazu Kubo and Toshihide Yamashita


DOI: 10.2174/157488907782411738




Therapeutic Treatment of Alzheimers Disease Using Metal Complexing Agents

, 2(3): 180 - 187

Katherine A. Price, Peter J. Crouch and Anthony R. White


DOI: 10.2174/157488907782411774




BACE Inhibitors as Potential Therapeutics for Alzheimers disease

, 2(3): 188 - 199

Genevieve Evin and Vijaya B. Kenche


DOI: 10.2174/157488907782411783




Potassium Channel Blockers and Openers as CNS Neurologic Therapeutic Agents

, 2(3): 200 - 228

Susan I.V. Judge, Paul J. Smith, Peggy E. Stewart and Christopher T. Bever Jr.


DOI: 10.2174/157488907782411765




Translating Genetic Findings into Therapy in Parkinson Disease

, 2(3): 229 - 237

Sagrario M. Palomo and Adriano Jimenez-Escrig


DOI: 10.2174/157488907782411747




Therapeutic Approach of Histamine H3 Receptors in Obesity

, 2(3): 238 - 240

Takayuki Masaki and Hironobu Yoshimatsu


DOI: 10.2174/157488907782411792




In Search of Novel and Therapeutically Significant Melatoninergic Ligands

, 2(3): 241 - 245

Sejal M. Mody, Yueqing Hu, Maurice K.C. Ho and Yung H. Wong


DOI: 10.2174/157488907782411756




Patent Selections

, 2(3): 246 - 249

Bentham Science Publishers


DOI: 10.2174/157488907782411729




Webmaster Contact: info@benthamscience.org
Copyright © 2018 Bentham Science